FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
In combination with docetaxel, the U.S. Food and Drug Administration (FDA) has approved Bayer’s Nubeqa for the treatment of hormone-sensitive metastatic prostate cancer (mHSPC).Nubeqa (darolutamide) was previously approved for the treatment of non-metastatic castration-resistant prostate ... [Read]
Emergent executes a letter of intent to acquire Evolutionary Biologics; former L’Oréal president Jim Morrison will become Emergent’s full-time chief executive officer.
Emergent Health Corp. (“Emergent”) (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc. Biologics, Inc. is a new type of biologics company with a specific mission: to provide the ... [Read]
Chronic Disease Increasing Need for Specialty Pharmacy Services
The average American’s lifespan may have increased to 78 years old, but chronic diseases are are still prevalent. According to the CDC, six in 10 adults in the US have a chronic disease and it ... [Read]
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health ... [Read]
Senate Bill Decriminalizing Psychedelics Could Help Reverse Some ‘War on Drugs’ Impacts
The global need for effective mental health treatment has led to the growing push for the legalization of psychedelic therapies, pushing the market into the mainstream. Last week, Michigan Senator Jeff Irwin introduced legislation that ... [Read]
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
The damage done by the opioid epidemic has caused families grief and loss, but recent developments in the case against Purdue Pharma will see some restitution for the family. A potential $10 billion will be ... [Read]
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
The early 1970s saw psychedelics and psilocybin products made illegal in the US in the war on drugs. Decades later, new research indicates the medical potential of psilocybin and psychedelics in the treatment of chronic ... [Read]
Telehealth Boom Is Driving this Mental Health Company’s Progress
Telehealth services boomed during 2020, as patients stuck at home required safe access to vital services, and are expected to continue post-pandemic. Before the public health emergence, only 14,000 Medicare beneficiaries received telehealth services per ... [Read]
Psychedelic Decriminalization Creating Market Opportunities
What was once a war on drugs has turned into a public push for the decriminalization and legalization of illegal drugs with potential therapeutic benefits. Legalization efforts began with marijuana in 2018, creating a booming ... [Read]
Investing in Pharmaceuticals: Small-Cap Pharmaceutical Stocks and ETFs
The global pharmaceutical market has been growing at a rapid rate in recent years and is expected to reach $1.57 trillion USD by 2023, signaling a major opportunity for investors to cash in on pharmaceutical stocks. ... [Read]